Results 1 to 10 of about 132,589 (180)

Nonsteroidal anti-inflammatory drug-induced colopathy: An uncommon cause of positive immunochemical faecal occult blood test in the program for colorectal cancer screening [PDF]

Vojnosanitetski Pregled, 2021
Introduction. Nonsteroidal anti-inflammatory drug-induced colopathy is an uncommon condition associated with the long-term use of enteric-coated and slow-release nonsteroidal anti-inflammatory drugs.
Smolović Brigita, Vučković Ljiljana, Borozan Sanja, Vukčević Batrić   +3 more
doaj   +1 more source

Fecal occult blood testing in colorectal cancer screening programs

Исследования и практика в медицине, 2022
Colorectal carcinoma (CRC) is the third most common cancer worldwide and ranks second as a cause of cancer mortality. CRC screening is carried out in many countries for detection early-stage CRC and its prevention by removing precancerous lesions, and ...
N. V. Severskaya, A. A. Nevolskikh, V. A. Avdeenko, Zh. V. Hailova, S. A. Ivanov   +4 more
doaj   +1 more source

Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis

GE: Portuguese Journal of Gastroenterology, 2021
Background and Objective: Colorectal cancer (CRC) is one of the most common cancers in Europe. Recently, new data from the USA and Europe revealed an increase in the incidence of CRC in individuals aged <55 years and a reduction in those aged > ...
Pedro Currais, Susana Mão de Ferro, Miguel Areia, Inês Marques, Alexandra Mayer, António Dias Pereira   +5 more
doaj   +1 more source

The Use of M2-Pyruvate Kinase as a Stool Biomarker for Detection of Colorectal Cancer in Tertiary Teaching Hospital: A Comparative Study [PDF]

Annals of Coloproctology, 2020
Purpose Guaiac fecal occult blood test (gFOBT) has been the standard for colorectal screening but it has low sensitivity and specificity. This study evaluated the use of fecal tumor M2-pyruvate kinase (M2-PK) for detection of colorectal cancer and to ...
Shahidah Che Alhadi, Wan Zainira Wan Zain, Zalina Zahari, Mohd Nizam Md Hashim, Syed Hassan Syed Abd. Aziz, Zaidi Zakaria, Michael Pak-Kai Wong, Andee Dzulkarnaen Zakaria   +7 more
doaj   +1 more source

Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study

Frontiers in Medicine, 2021
Objective: The diagnostic efficiency of the quantitative fecal immunochemical test (qFIT) has large variations in colorectal cancer (CRC) screening. We aimed to explore whether the practical sample collection operant training could improve the diagnostic
Ru-chen Zhou, Ru-chen Zhou, Ru-chen Zhou, Pei-zhu Wang, Pei-zhu Wang, Pei-zhu Wang, Yue-yue Li, Yue-yue Li, Yue-yue Li, Yan Zhang, Yan Zhang, Yan Zhang, Ming-jun Ma, Ming-jun Ma, Ming-jun Ma, Fan-yi Meng, Fan-yi Meng, Fan-yi Meng, Chao Liu, Chao Liu, Chao Liu, Xiao-yun Yang, Xiao-yun Yang, Xiao-yun Yang, Ming Lv, Xiu-li Zuo, Xiu-li Zuo, Xiu-li Zuo, Yan-qing Li, Yan-qing Li, Yan-qing Li   +30 more
doaj   +1 more source

Colorectal cancer testing rates after implementation of an organised screening programme in Vaud, Switzerland

Swiss Medical Weekly, 2023
AIMS OF THE STUDY: Canton Vaud, Switzerland, implemented an organised colorectal cancer  screening programme with colonoscopy and faecal occult blood tests in 2015, 4 to 6 years ahead of neighbouring cantons.
Christina Hempel-Bruder, Lamprini Syrogiannouli, Rémi Schneider, Sarah Bissig, Oliver Senn, Kali Tal, Jean-Luc Bulliard, Cyril Ducros, Christian P. R. Schmid, Reto Auer, Kevin Selby   +10 more
doaj   +1 more source

Role of Immunological Method of Fecal Occult Blood Test for Screening Colorectal Diseases

Bangabandhu Sheikh Mujib Medical University Journal, 2011
Background: Colorectal diseases specially colorectal carcinoma is one of the major health problems throughout the world. Therefore, early diagnosis of these diseases is mandatory.
Farida Yeasmin, Mohammad Asadur Rahman, Akmat Ali, Tuhin Sultana, Md Quddusur Rahman, AN Nashimuddin Ahmed, Projesh Kumar Roy   +6 more
doaj   +1 more source

Risk for Colorectal Cancer in Patients with Serially Positive Fecal Immunochemistry Test in an Annual Screening Program

Journal of the Anus, Rectum and Colon, 2021
Objectives: There are patients who do not undergo colonoscopy even if the fecal immunochemistry test (FIT) results are positive and even with repeated positive test results the following year.
Takuji Kawamura, Kana Amamiya, Naonori Inoue, Naokuni Sakiyama, Yusuke Okada, Kasumi Sanada, Mai Kamaguchi, Kenichi Nishioji, Kiyohito Tanaka, Koji Uno, Kenjiro Yasuda   +10 more
doaj   +1 more source

Risk of Diabetes in Subjects with Positive Fecal Immunochemical Test: A Nationwide Population-Based Study [PDF]

Endocrinology and Metabolism, 2021
Background Positive fecal immunochemical test (FIT) results have been recently suggested as a risk factor for systemic inflammation. Diabetes induces inflammation in the gastrointestinal tract via several ways. We investigated the association between FIT
Kwang Woo Kim, Hyun Jung Lee, Kyungdo Han, Jung Min Moon, Seung Wook Hong, Eun Ae Kang, Jooyoung Lee, Hosim Soh, Seong-Joon Koh, Jong Pil Im, Joo Sung Kim   +10 more
doaj   +1 more source

Use of faecal immunochemical tests common in patients with suspected colorectal cancer but unrelated to travel distance to secondary care: a population-based study from Swedish primary care

Scandinavian Journal of Primary Health Care, 2022
Background Evidence is increasing for the use of faecal immunochemical tests (FITs) for occult blood as diagnostic tools when colorectal cancer can be suspected.
Cecilia Högberg, Olof Cronberg, Hans Thulesius, Mikael Lilja, Stefan Jansson, Ulf Gunnarsson   +5 more
doaj   +1 more source